Visual Field Analysis and Electrodiagnostic Testing in Neuro-Ophthalmology

Visual Field Analysis and Electrodiagnostic Testing in Neuro-Ophthalmology

Executive Summary

This document provides a comprehensive synthesis of neuro-ophthalmic diagnostic procedures, focusing on visual field (VF) assessment and electrodiagnostic testing. The primary function of visual field testing is to detect, characterize, and localize lesions along the visual pathway. By correlating the specific pattern of a visual field defect—such as a bitemporal hemianopia or a homonymous quadrantanopia—with the underlying neuroanatomy, clinicians can pinpoint pathology from the optic nerve to the occipital cortex. The document details the spectrum of testing methodologies, from clinical confrontation tests to the highly sensitive and quantitative automated static perimetry (e.g., Humphrey), which is the standard of care in neuro-ophthalmology.

Complementing visual field analysis, electrodiagnostic tests offer objective, quantitative data on the functional integrity of the visual system. The Visual Evoked Potential (VEP) assesses the entire pathway from the retinal ganglion cells to the visual cortex, proving invaluable in diagnosing conditions like optic neuritis and multiple sclerosis, where prolonged signal latency is a key indicator. The Electroretinogram (ERG) specifically measures retinal function, allowing clinicians to differentiate retinal pathologies from optic nerve or retro-chiasmal disease. Together, these diagnostic modalities provide a powerful framework for the precise evaluation and management of neuro-ophthalmic disorders.

Part I: Visual Field (VF) Assessment

Fundamentals of the Visual Field

The visual field is conceptually described as an "island of vision surrounded by a sea of darkness." It represents a three-dimensional hill of vision where the peak corresponds to the fovea, the point of highest visual acuity.

• Normal Extents: The monocular visual field extends approximately 90° temporally, 60° nasally, 75° superiorly, and 70° inferiorly from the point of fixation.
• Anatomical Correlation: The visual field has an inverted and reversed relationship with the retina.
• The superior visual field projects onto the inferior retina.
• The inferior visual field projects onto the superior retina.
• The temporal visual field projects onto the nasal retina.
• The nasal visual field projects onto the temporal retina.
• Physiologic Blind Spot: This naturally occurring scotoma corresponds to the optic disc, which lacks photoreceptors. It is located approximately 15 degrees temporally from the point of fixation in each eye.

Accurate assessment requires standardization. Factors such as the patient's refractive status must be corrected, as an overcorrection of just 1 diopter can cause a 3.6dB reduction in sensitivity. Serial comparisons demand consistent background luminance, stimulus size, intensity, and exposure times.

Methods of Visual Field Testing

Various methods exist to evaluate the visual field, each with specific applications and limitations.

Key Details of Perimetry Techniques

• Kinetic Perimetry (Goldmann):
• Stimulus Size: Represented by Roman numerals I (smallest) through V (largest).
• Stimulus Intensity: Represented by Arabic numerals (1-4) and lowercase letters ('a' darkest to 'e' brightest).
• Automated Static Perimetry (Humphrey):
• Common Programs: The Swedish Interactive Thresholding Algorithm (SITA) is widely used, with SITA Standard (~6 minutes/eye) and SITA Fast (~3 minutes/eye) being common variants.
• Testing Principle: Determines the minimum brightness (threshold) a patient can see at various fixed points in their central visual field.

Interpreting Automated Perimetry Results

Interpreting a Humphrey Visual Field printout requires assessing reliability and analyzing defect patterns.

• Reliability Indices:
• Fixation Losses: Unreliable if >20%.
• False Positives: Patient responds when no stimulus is present. Unreliable if >33%.
• False Negatives: Patient fails to respond to a stimulus that was previously seen. Unreliable if >33%.
• Key Metrics:
• Grayscale: A visual representation of the field, useful for quick pattern recognition.
• Total Deviation: Compares the patient's threshold at each point to an age-matched normal value.
• Pattern Deviation: Adjusts for generalized depression (e.g., from a cataract) to highlight focal, localized defects.
• Global Indices:
• Mean Deviation (MD): A measure of the overall, average depression or elevation of the visual field.
• Pattern Standard Deviation (PSD): Measures focal loss or variability within the field. An increased PSD is more indicative of glaucomatous field loss than changes in MD.
• Short-term Fluctuation (SF): Indicates the consistency of patient responses by re-testing thresholds at ten preselected points.

Localization of Lesions via Visual Field Defects

The pattern of vision loss is a critical tool for localizing pathology along the visual pathway.

• Terminology:
• Scotoma: An area of depressed vision surrounded by an area of normal vision.
• Homonymous: Defects are in the corresponding regions of the VF in both eyes (e.g., both right fields).
• Congruousness: The degree to which the field defects in the two eyes match in shape, size, and depth. The more posterior the lesion in the retro-chiasmal pathway, the more congruous the defect.
• Respect for Meridians: Defects that respect the vertical midline are typically caused by chiasmal or retro-chiasmal lesions. Defects respecting the horizontal midline are more often due to retinal or optic nerve pathology.

Clinical Correlations and Case Insights

• Optic Neuritis: This inflammatory condition can produce any type of visual field defect. While central scotomas are common, the most frequent finding is diffuse depression (48.2% of cases). Other patterns include altitudinal (15.6%), quadrantanopic (6.0%), and cecocentral defects (4.5%). A classic presentation involves a young patient with painful vision loss in one eye and a Relative Afferent Pupillary Defect (RAPD).
• Non-Organic (Functional) Vision Loss: A critical diagnostic clue is a profound, unilateral vision loss (e.g., No Light Perception - NLP) in the absence of a corresponding RAPD. The afferent pupillary pathway is an objective measure, and its integrity despite severe subjective vision loss strongly suggests a non-organic cause.

Part II: Electrodiagnostic Testing

Electrodiagnostic tests provide objective information about the function of the retina and visual pathway, which is particularly useful when symptoms are vague or clinical examination is inconclusive.

Visual Evoked Potential (VEP)

The VEP measures the electrical response of the visual cortex to a light stimulus, assessing the functional integrity of the entire visual pathway from the retinal ganglion cells to the occipital lobe.

• Methodology:
• Stimuli: Can be a Pattern VEP (alternating checkerboard, standard) or a Flash VEP (used for uncooperative subjects or those with opaque media).
• Electrodes: An active electrode is placed over the vertex, a reference electrode over the occipital region (inion), and a ground electrode on the forehead.
• Key Parameters:
• Amplitude: The height of the P100 wave, representing the strength of the signal. Amplitude is primarily affected in compressive or ischemic lesions.
• Latency: The time from stimulus presentation to the peak of the P100 wave. Latency is the primary parameter affected in demyelinating diseases.
• Clinical Applications:
• Multiple Sclerosis (MS) & Optic Neuritis: The hallmark finding is an increased latency of the P100 wave, which can be seen in 90% of MS patients, irrespective of visual symptoms. Amplitude may also be decreased.
• Compressive/Toxic Neuropathies: These conditions typically cause a more predominant decrease in amplitude than an increase in latency.
• Objective Assessment: VEP can be used to objectively assess visual function in non-verbal patients (e.g., infants), suspected amblyopia, or cases of suspected non-organic vision loss.

Electroretinogram (ERG)

The ERG measures the mass electrical response of the retina to a flash of light. It is essential for differentiating retinal diseases from optic nerve pathology.

• Methodology:
• Stimulus: A Ganzfeld bowl provides diffuse, uniform retinal stimulation.
• Electrodes: An active recording electrode is placed on the eye (e.g., contact lens, DTL fiber, gold foil), a reference electrode on the forehead, and a ground electrode on the earlobe.
• Conditions: Tests are performed under dark-adapted (scotopic) conditions to assess rod function and light-adapted (photopic) conditions to assess cone function.
• Key Waveforms:
• a-wave: The initial negative deflection, originating from the photoreceptors (rods and cones).
• b-wave: The subsequent positive deflection, originating from bipolar and Müller cells.
• Specialized ERG Techniques:
• Bright Flash ERG: Uses a stimulus 10,000 times brighter than normal to assess retinal function through opaque media like dense cataracts or vitreous hemorrhage.
• Multifocal ERG (mfERG): Generates a topographic map of retinal function, identifying localized areas of dysfunction.
• Pattern ERG (pERG): Specifically assesses the function of the innermost retinal layers, including the retinal ganglion cells.

Clinical Applications and Differentiating Findings

The ERG is critical for diagnosing a range of retinal conditions, which is essential for the neuro-ophthalmologist to rule out retinal causes of vision loss.